Anti Osteoporosis Therapy And Fracture Healing Market

Anti-Osteoporosis Therapy and Fracture Healing Market: Europe to Closely Trail North America with Leading Growth Rate: Global Industry Analysis (2012 - 2017) & Opportunity Assessment (2018 - 2026)

Ask The Analyst Customization Available Request Methodology

Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, block chain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets. Among the various drug types in the global anti-osteoporosis therapy and fracture healing market, the largest share was occupied by Bisphosphonates with 38.4% in 2017, and this is expected to reach around US$ 5,941 Mn by the end of 2026.

North America to Lead the Global Market in the Long Run

By the end of 2026, North America is expected to dominate the market and reach a valuation of around US$ 4,895 Mn. This growth can be attributed to expanding interest in R&D for the disclosure of new and inventive medications, rising rate of the geriatric populace, and expanding commonness of way of life related illnesses in the region. The Asia Pacific anti-osteoporosis therapy and fracture healing market is expected to display high development rates in the conjectured time frame. India and China are relied upon to be the quickest developing markets for anti-osteoporosis therapy and fracture healing in the Asia Pacific region. A portion of the key variables driving the worldwide anti-osteoporosis therapy and fracture healing market in developing nations includes rising awareness about osteoporosis, a vast pool of patients, rising occurrence of geriatric populace, changing ways of life and expanding social insurance use.

Worldwide anti-osteoporosis therapy and fracture healing market is expected to grow incessantly over the years ahead attributing to quick development of the healthcare industry and healthcare expenditure in developing economies such as China and India, and expanding advantages of anti-osteoporosis therapies over different osteoporosis treatments.

anti-osteoporosis-therapy-and-fracture-healing-market.jpg

Bisphosphonates to be Key Drug Type in North America

The global anti-osteoporosis therapy and fracture healing market has been segmented on the basis of drug type into bisphosphonates, calcitonin, estrogen or hormone replacement therapy, biologics, and anabolics. Biophosphonates is expected to emerge as the most preferred drug type in North America owing to its benefits and price point. Moreover, bisphosphonates, estrogen therapy, and selective estrogen receptor modulators (SERMs) are considered core classes in the global osteoporosis drugs market. Nevertheless, as the drugs belonging to these classes were invented decades ago, patents of most of the molecules and formulations have already expired or scheduled to expire by 2020.

Companies such as Forteo have increased the lumbar spine bone mineral density by 0.059 grams per square centimeters in comparison to alendronate, which increased it by 0.028 grams per square centimeters. Furthermore, bisphosphonates and estrogen therapy are identified as drug classes with chronic side effects such as jaw death, vaginal bleeding and uterus cancer. These chronic side effects have risen the need for the development of new drugs with less or virtually no side effects. SERM drugs (Evista, Duavee) were launched to overcome the side effects of estrogens. Chronic side effects of established drugs is another factor that is expected to trigger the demand for new drug development and is anticipated to support the growth of the osteoporosis drugs market in the region over the course of the forecast period.

A new market research report has been published in the repository of Future Market Insights (FMI) on the anti-osteoporosis therapy and fracture healing market. The report provides incisive insights on the chronological growth trajectory of the market along with the present and future growth prospects present in the market. The report offers an exclusive analysis of the global market along with regional and segment based insights.

Anti-Osteoporosis Therapy and Fracture Healing Market: Overview 

The report presents the summation of the market including an official abstract that draws out the centre examples progressing in the market. It furthermore discusses on a couple of facets, for example, drivers, obstacles, and prospects that have been found in the global market. It also acquaints readers with figures related to volume, value, and development rate of the market from a growth point of view. With respect to market segmentation, each segment is analysed in detail and presented in the report. The report also presents an evaluation in the light of the market circumstance and presents a value chain analysis of the products and applications in question. A year to year progression of the market has likewise been offered in the report for the reader to be particularly aware of the changing scenario of the global market.

Anti-Osteoporosis Therapy and Fracture Healing Market: Taxonomy

Region

Drug Type

Route of Administration

Distribution Channel

  • North America

  • Bisphosphonates

  • Oral

  • Hospital Pharmacies

  • Latin America

  • Calcitonin

  • Injectable

  • Private Clinics

  • Europe

  • Estrogen or Hormone Replacement Therapy

 

  • Drug Stores

  • Japan

  • Biologics

 

  • Retail Pharmacies

  • APEJ

  • Anabolics

 

  • E-Commerce

  • MEA

 

 

 

Anti-Osteoporosis Therapy and Fracture Healing Market: Research Methodology

The report is the end result of the cautious research work of the market analysts employing reliable sources. The information introduced has been studied carefully by industry experts of FMI. The data that has been presented here has been assembled from various tried and tested sources. The figures have also been checked by the examiners and can be used to settle on key decisions and to formulate strategies.

Anti-Osteoporosis Therapy and Fracture Healing Market: Competitive Landscape

The market study conveys an immense outlook on the engaged scene of the overall anti-osteoporosis therapy and fracture healing market. It features the competition prevalent among the present vendors in the market and also lays emphasis on the future circumstance of the market. The profile of the players is based on a SWOT examination sought down by company angle, product portfolio, strategies, finance related information, and year-to-year projections. The organisations have been explored minutely covering their key developments, innovations as well as mergers and acquisitions and agreements with other prominent organisations. The report also includes a PEST analysis for making it a convenient read for readers.

Reasons Why Our Report is Trustworthy

The reports made by our industry analysts are credible and have been researched and validated from several primary and secondary resources. What makes us unique is the fact that along with presenting an analysis of the market’s historical and present scenario, we also present a forecast review of the market for the benefit of our readers. The presentation is unique in the form of various charts, tables, and diagrams. Every bit of information present in the market research report is unique. Expert opinions are also present in the report that can be directly used by the readers to make future decisions.

Anti Osteoporosis Therapy And Fracture Healing Market Reports - Table of Contents

1. Global Anti-Osteoporosis Therapy and Fracture Healing Market - Executive Summary

2. Global Anti-Osteoporosis Therapy and Fracture Healing Market Overview

2.1. Introduction

2.1.1. Global Anti-Osteoporosis Therapy and Fracture Healing Market Taxonomy

2.1.2. Global Anti-Osteoporosis Therapy and Fracture Healing Market Definition

2.2. Global Anti-Osteoporosis Therapy and Fracture Healing Market Size (US$ Mn) and Forecast, 2012-2026

2.2.1. Global Anti-Osteoporosis Therapy and Fracture Healing Market Y-o-Y Growth

2.3. Global Anti-Osteoporosis Therapy and Fracture Healing Market Dynamics

2.4. PEST Analysis

2.5. Regulatory Scenario

2.6. Disease Epidemiology

2.7. Pipeline Drug Analysis

2.8. Supplier List

2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Anti-Osteoporosis Therapy and Fracture Healing Market Analysis and Forecast 2012-2026 

3.1. Global Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast By Drug Type, 2012-2026

3.1.1. Bisphosphonates Market Size and Forecast, 2012-2026

3.1.1.1. Revenue (US$ Mn) Comparison, By Region

3.1.1.2. Market Share Comparison, By Region

3.1.1.3. Y-o-Y growth Comparison, By Region

3.1.2. Calcitonin Market Size and Forecast, 2012-2026

3.1.2.1. Revenue (US$ Mn) Comparison, By Region

3.1.2.2. Market Share Comparison, By Region

3.1.2.3. Y-o-Y growth Comparison, By Region

3.1.3. Estrogen or Hormone Replacement Therapy Market Size and Forecast, 2012-2026

3.1.3.1. Revenue (US$ Mn) Comparison, By Region

3.1.3.2. Market Share Comparison, By Region

3.1.3.3. Y-o-Y growth Comparison, By Region

3.1.4. Biologics Market Size and Forecast, 2012-2026

3.1.4.1. Revenue (US$ Mn) Comparison, By Region

3.1.4.2. Market Share Comparison, By Region

3.1.4.3. Y-o-Y growth Comparison, By Region

3.1.5. Anabolics Market Size and Forecast, 2012-2026

3.1.5.1. Revenue (US$ Mn) Comparison, By Region

3.1.5.2. Market Share Comparison, By Region

3.1.5.3. Y-o-Y growth Comparison, By Region

3.2. Global Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast By Route of Administration, 2012-2026

3.2.1. Oral Market Size and Forecast, 2012-2026

3.2.1.1. Revenue (US$ Mn) Comparison, By Region

3.2.1.2. Market Share Comparison, By Region

3.2.1.3. Y-o-Y growth Comparison, By Region

3.2.2. Injectable Market Size and Forecast, 2012-2026

3.2.2.1. Revenue (US$ Mn) Comparison, By Region

3.2.2.2. Market Share Comparison, By Region

3.2.2.3. Y-o-Y growth Comparison, By Region

3.3. Global Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast By Distribution Channel, 2012-2026

3.3.1. Hospital Pharmacies Market Size and Forecast, 2012-2026

3.3.1.1. Revenue (US$ Mn) Comparison, By Region

3.3.1.2. Market Share Comparison, By Region

3.3.1.3. Y-o-Y growth Comparison, By Region

3.3.2. Private Clinics Market Size and Forecast, 2012-2026

3.3.2.1. Revenue (US$ Mn) Comparison, By Region

3.3.2.2. Market Share Comparison, By Region

3.3.2.3. Y-o-Y growth Comparison, By Region

3.3.3. Drug Stores Market Size and Forecast, 2012-2026

3.3.3.1. Revenue (US$ Mn) Comparison, By Region

3.3.3.2. Market Share Comparison, By Region

3.3.3.3. Y-o-Y growth Comparison, By Region

3.3.4. Retail Pharmacies Market Size and Forecast, 2012-2026

3.3.4.1. Revenue (US$ Mn) Comparison, By Region

3.3.4.2. Market Share Comparison, By Region

3.3.4.3. Y-o-Y growth Comparison, By Region

3.3.5. E-Commerce Market Size and Forecast, 2012-2026

3.3.5.1. Revenue (US$ Mn) Comparison, By Region

3.3.5.2. Market Share Comparison, By Region

3.3.5.3. Y-o-Y growth Comparison, By Region

4. North America Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026

4.1. Revenue (US$ Mn) Comparison, By Country 

4.2. Revenue (US$ Mn) Comparison, By Drug Type 

4.3. Revenue (US$ Mn) Comparison, By Route of Administration 

4.4. Revenue (US$ Mn) Comparison, By Distribution Channel 

5. Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026

5.1. Revenue (US$ Mn) Comparison, By Country 

5.2. Revenue (US$ Mn) Comparison, By Drug Type 

5.3. Revenue (US$ Mn) Comparison, By Route of Administration 

5.4. Revenue (US$ Mn) Comparison, By Distribution Channel 

6. Europe Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026

6.1. Revenue (US$ Mn) Comparison, By Country 

6.2. Revenue (US$ Mn) Comparison, By Drug Type 

6.3. Revenue (US$ Mn) Comparison, By Route of Administration 

6.4. Revenue (US$ Mn) Comparison, By Distribution Channel 

7. Japan Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026

7.1. Revenue (US$ Mn) Comparison, By Country 

7.2. Revenue (US$ Mn) Comparison, By Drug Type 

7.3. Revenue (US$ Mn) Comparison, By Route of Administration 

7.4. Revenue (US$ Mn) Comparison, By Distribution Channel 

8. APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026

8.1. Revenue (US$ Mn) Comparison, By Country 

8.2. Revenue (US$ Mn) Comparison, By Drug Type 

8.3. Revenue (US$ Mn) Comparison, By Route of Administration 

8.4. Revenue (US$ Mn) Comparison, By Distribution Channel 

9. MEA Anti-Osteoporosis Therapy and Fracture Healing Market Size and Forecast, 2012-2026

9.1. Revenue (US$ Mn) Comparison, By Country 

9.2. Revenue (US$ Mn) Comparison, By Drug Type 

9.3. Revenue (US$ Mn) Comparison, By Route of Administration 

9.4. Revenue (US$ Mn) Comparison, By Distribution Channel 

10. Global Anti-Osteoporosis Therapy and Fracture Healing Market Company Share, Competition Landscape and Company Profiles

10.1. Company Share Analysis

10.2. Competition Landscape

10.3. Company Profiles

10.3.1. Eli Lilly and Company

10.3.2. Pfizer, Inc.

10.3.3. Amgen Inc.

10.3.4. Merck and Company Inc.

10.3.5. Novartis International AG.

10.3.6. Johnson & Johnson

10.3.7. F. Hoffmann La Roche Ltd.

10.3.8. Teva Pharmaceutical Industries Ltd.

10.3.9. GlaxoSmithKline Plc.

10.3.10. Others

11. Research Methodology

12. Secondary and Primary Sources

13. Assumptions and Acronyms

14. Disclaimer

Anti Osteoporosis Therapy And Fracture Healing Market Reports - List of Tables

TABLE 1 Global Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), 2012-2017

TABLE 2 Global Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), 2018-2026

TABLE 3 Global Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn) and Y-o-Y, 2017-2026

TABLE 4 Global Bisphosphonates Segment Value (US$ Mn), By Region 2012-2017

TABLE 5 Global Bisphosphonates Segment Value (US$ Mn), By Region 2018-2026

TABLE 6 Global Bisphosphonates Segment Market Share, By Region 2012-2017

TABLE 7 Global Bisphosphonates Segment Market Share, By Region 2018-2026

TABLE 8 Global Bisphosphonates Segment Y-o-Y, By Region 2017-2026

TABLE 9 Global Calcitonin Segment Value (US$ Mn), By Region 2012-2017

TABLE 10 Global Calcitonin Segment Value (US$ Mn), By Region 2018-2026

TABLE 11 Global Calcitonin Segment Market Share, By Region 2012-2017

TABLE 12 Global Calcitonin Segment Market Share, By Region 2018-2026

TABLE 13 Global Calcitonin Segment Y-o-Y, By Region 2017-2026

TABLE 14 Global Estrogen or Hormone Replacement Therapy Segment Value (US$ Mn), By Region 2012-2017

TABLE 15 Global Estrogen or Hormone Replacement Therapy Segment Value (US$ Mn), By Region 2018-2026

TABLE 16 Global Estrogen or Hormone Replacement Therapy Segment Market Share, By Region 2012-2017

TABLE 17 Global Estrogen or Hormone Replacement Therapy Segment Market Share, By Region 2018-2026

TABLE 18 Global Estrogen or Hormone Replacement Therapy Segment Y-o-Y, By Region 2017-2026

TABLE 19 Global Biologics Segment Value (US$ Mn), By Region 2012-2017

TABLE 20 Global Biologics Segment Value (US$ Mn), By Region 2018-2026

TABLE 21 Global Biologics Segment Market Share, By Region 2012-2017

TABLE 22 Global Biologics Segment Market Share, By Region 2018-2026

TABLE 23 Global Biologics Segment Y-o-Y, By Region 2017-2026

TABLE 24 Global Anabolics Segment Value (US$ Mn), By Region 2012-2017

TABLE 25 Global Anabolics Segment Value (US$ Mn), By Region 2018-2026

TABLE 26 Global Anabolics Segment Market Share, By Region 2012-2017

TABLE 27 Global Anabolics Segment Market Share, By Region 2018-2026

TABLE 28 Global Anabolics Segment Y-o-Y, By Region 2017-2026

TABLE 29 Global Oral Segment Value (US$ Mn), By Region 2012-2017

TABLE 30 Global Oral Segment Value (US$ Mn), By Region 2018-2026

TABLE 31 Global Oral Segment Market Share, By Region 2012-2017

TABLE 32 Global Oral Segment Market Share, By Region 2018-2026

TABLE 33 Global Oral Segment Y-o-Y, By Region 2017-2026

TABLE 34 Global Injectable Segment Value (US$ Mn), By Region 2012-2017

TABLE 35 Global Injectable Segment Value (US$ Mn), By Region 2018-2026

TABLE 36 Global Injectable Segment Market Share, By Region 2012-2017

TABLE 37 Global Injectable Segment Market Share, By Region 2018-2026

TABLE 38 Global Injectable Segment Y-o-Y, By Region 2017-2026

TABLE 39 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017

TABLE 40 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026

TABLE 41 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017

TABLE 42 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026

TABLE 43 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026

TABLE 44 Global Private Clinics Segment Value (US$ Mn), By Region 2012-2017

TABLE 45 Global Private Clinics Segment Value (US$ Mn), By Region 2018-2026

TABLE 46 Global Private Clinics Segment Market Share, By Region 2012-2017

TABLE 47 Global Private Clinics Segment Market Share, By Region 2018-2026

TABLE 48 Global Private Clinics Segment Y-o-Y, By Region 2017-2026

TABLE 49 Global Drug Stores Segment Value (US$ Mn), By Region 2012-2017

TABLE 50 Global Drug Stores Segment Value (US$ Mn), By Region 2018-2026

TABLE 51 Global Drug Stores Segment Market Share, By Region 2012-2017

TABLE 52 Global Drug Stores Segment Market Share, By Region 2018-2026

TABLE 53 Global Drug Stores Segment Y-o-Y, By Region 2017-2026

TABLE 54 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017

TABLE 55 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026

TABLE 56 Global Retail Pharmacies Segment Market Share, By Region 2012-2017

TABLE 57 Global Retail Pharmacies Segment Market Share, By Region 2018-2026

TABLE 58 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026

TABLE 59 Global E-Commerce Segment Value (US$ Mn), By Region 2012-2017

TABLE 60 Global E-Commerce Segment Value (US$ Mn), By Region 2018-2026

TABLE 61 Global E-Commerce Segment Market Share, By Region 2012-2017

TABLE 62 Global E-Commerce Segment Market Share, By Region 2018-2026

TABLE 63 Global E-Commerce Segment Y-o-Y, By Region 2017-2026

TABLE 64 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2012-2017

TABLE 65 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2018-2026

TABLE 66 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2012-2017

TABLE 67 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2018-2026

TABLE 68 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2012-2017

TABLE 69 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2018-2026

TABLE 70 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 71 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 72 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2012-2017

TABLE 73 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2018-2026

TABLE 74 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2012-2017

TABLE 75 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2018-2026

TABLE 76 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2012-2017

TABLE 77 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2018-2026

TABLE 78 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 79 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 80 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2012-2017

TABLE 81 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2018-2026

TABLE 82 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2012-2017

TABLE 83 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2018-2026

TABLE 84 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2012-2017

TABLE 85 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2018-2026

TABLE 86 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 87 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 88 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2012-2017

TABLE 89 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2018-2026

TABLE 90 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2012-2017

TABLE 91 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2018-2026

TABLE 92 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2012-2017

TABLE 93 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2018-2026

TABLE 94 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2

TABLE 95 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 96 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2012-2017

TABLE 97 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2018-2026

TABLE 98 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2012-2017

TABLE 99 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2018-2026

TABLE 100 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2012-2017

TABLE 101 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2018-2026

TABLE 102 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 103 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2018-2026

TABLE 104 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2012-2017

TABLE 105 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2018-2026

TABLE 106 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2012-2017

TABLE 107 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2018-2026

TABLE 108 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2012-2017

TABLE 109 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2018-2026

TABLE 110 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2012-2017

TABLE 111 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2018-2026

Anti Osteoporosis Therapy And Fracture Healing Market Reports - List of Figures

FIG. 1 Global Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), 2012-2017

FIG. 2 Global Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn) Forecast, 2018-2026

FIG. 3 Global Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn) and Y-o-Y, 2017-2026

FIG. 4 Global Bisphosphonates Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 5 Global Bisphosphonates Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 6 Global Bisphosphonates Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 7 Global Calcitonin Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 8 Global Calcitonin Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 9 Global Calcitonin Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 10 Global Estrogen or Hormone Replacement Therapy Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 11 Global Estrogen or Hormone Replacement Therapy Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 12 Global Estrogen or Hormone Replacement Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 13 Global Biologics Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 14 Global Biologics Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 15 Global Biologics Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 16 Global Anabolics Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 17 Global Anabolics Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 18 Global Anabolics Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 19 Global Oral Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 20 Global Oral Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 21 Global Oral Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 22 Global Injectable Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 23 Global Injectable Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 24 Global Injectable Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 25 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 26 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 27 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 28 Global Private Clinics Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 29 Global Private Clinics Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 30 Global Private Clinics Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 31 Global Drug Stores Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 32 Global Drug Stores Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 33 Global Drug Stores Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 34 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 35 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 36 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 37 Global E-Commerce Segment Market Value (US$ Mn) By Region, 2012-2017

FIG. 38 Global E-Commerce Segment Market Value (US$ Mn) By Region, 2018-2026

FIG. 39 Global E-Commerce Segment Y-o-Y Growth Rate, By Region, 2017-2026

FIG. 40 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2012-2017

FIG. 41 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2018-2026

FIG. 42 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2012-2017

FIG. 43 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2018-2026

FIG. 44 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2012-2017

FIG. 45 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2018-2026

FIG. 46 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 47 North America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 48 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2012-2017

FIG. 49 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2018-2026

FIG. 50 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2012-2017

FIG. 51 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2018-2026

FIG. 52 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2012-2017

FIG. 53 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2018-2026

FIG. 54 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 55 Latin America Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 56 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2012-2017

FIG. 57 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2018-2026

FIG. 58 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2012-2017

FIG. 59 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2018-2026

FIG. 60 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2012-2017

FIG. 61 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2018-2026

FIG. 62 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 63 Europe Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 64 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2012-2017

FIG. 65 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2018-2026

FIG. 66 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2012-2017

FIG. 67 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2018-2026

FIG. 68 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 69 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2018-2026

FIG. 70 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 71 Japan Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 72 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2012-2017

FIG. 73 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2018-2026

FIG. 74 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2012-2017

FIG. 75 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2018-2026

FIG. 76 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2012-2017

FIG. 77 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2018-2026

FIG. 78 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 79 APEJ Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2018-2026

FIG. 80 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2012-2017

FIG. 81 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Country 2018-2026

FIG. 82 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2012-2017

FIG. 83 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Drug Type 2018-2026

FIG. 84 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2012-2017

FIG. 85 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Route of Administration 2018-2026

FIG. 86 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2012-2017

FIG. 87 MEA Anti-Osteoporosis Therapy and Fracture Healing Market Value (US$ Mn), By Distribution Channel 2018-2026